GEHC

+ Watchlist + Portfolio

GE HealthCare Technologies Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $74.62
52-Week Range: $58.75 – $89.77
Market Cap: $33.45B
P/E (TTM): 17.06
EPS (TTM): 4.34
Dividend Yield: 0.19%

Advanced Metrics

Price/Book: 3.05
PEG Ratio: 2.06
Return on Equity: 19.38%
Return on Assets: 5.13%
Gross Margin: 39.53%
Operating Margin: 14.98%
Profit Margin: 9.33%
Current Ratio: 1.26
Debt/Equity: 0.94
Total Debt: $10.54B
Free Cash Flow: $1.57B
Revenue Growth: 5.80%
Earnings Growth: 16.80%
Enterprise Value: $42.41B

GEHC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$18.34B	$19.55B	$19.67B	$20.63B
Cost of Revenue	$11.16B	$11.63B	$11.47B	$12.38B
Gross Profit	$7.18B	$7.92B	$8.21B	$8.25B
Research & Development	$1.03B	$1.21B	$1.31B	$1.26B
Selling, General & Admin	$3.63B	$4.28B	$4.27B	$4.22B
Operating Expenses	$4.66B	$5.49B	$5.58B	$5.49B
Operating Income	$2.52B	$2.44B	$2.63B	$2.76B
EBITDA	$3.23B	$3.51B	$3.67B	$3.79B
Pretax Income	$2.51B	$2.36B	$2.58B	$2.77B
Income Tax	$563.00M	$743.00M	$531.00M	$614.00M
Net Income	$1.92B	$1.57B	$1.99B	$2.08B
Diluted EPS	4.63	3.03	4.34	4.55
Diluted Shares	413.82M	458.00M	459.00M	458.00M

GEHC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.44B	$2.49B	$2.87B	$4.49B
Receivables	$3.99B	$4.31B	$4.36B	$4.85B
Inventory	$2.15B	$1.96B	$1.94B	$2.23B
Current Assets	$8.32B	$9.41B	$9.90B	$12.50B
Total Assets	$27.54B	$32.45B	$33.09B	$36.91B
Current Liabilities	$7.19B	$8.98B	$9.55B	$9.11B
Long-Term Debt	$8.23B	$8.44B	$7.45B	$9.49B
Total Debt	$8.63B	$9.86B	$9.38B	$10.46B
Total Liabilities	$17.95B	$25.14B	$24.44B	$26.31B
Retained Earnings	$0.00	$1.33B	$3.26B	$5.28B
Shareholders' Equity	$9.36B	$7.13B	$8.45B	$10.38B
Working Capital	$1.13B	$429.00M	$348.00M	$3.40B
Net Debt	$6.81B	$6.95B	$6.08B	$5.51B

GEHC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$2.11B	$2.10B	$1.95B	$1.99B
Capital Expenditure	-$310.00M	-$387.00M	-$401.00M	-$482.00M
Free Cash Flow	$1.80B	$1.71B	$1.55B	$1.50B
Depreciation & Amortisation	$633.00M	$610.00M	$580.00M	$578.00M
Stock-Based Compensation	$67.00M	$114.00M	$125.00M	$130.00M
Investing Cash Flow	-$398.00M	-$558.00M	-$914.00M	-$1.05B
Financing Cash Flow	-$822.00M	-$478.00M	-$573.00M	$617.00M
Dividends Paid	$0.00	-$41.00M	-$55.00M	-$64.00M
Share Repurchases	—	$0.00	$0.00	-$200.00M
Net Change in Cash	$893.00M	$1.06B	$464.00M	$1.56B

GEHC Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$5.01B	$5.14B	$5.70B	$5.13B	$5.29B
Cost of Revenue	$3.02B	$3.15B	$3.44B	$3.15B	$3.12B
Gross Profit	$1.98B	$1.99B	$2.26B	$1.98B	$2.18B
Research & Development	$302.00M	$292.00M	$323.00M	$345.00M	$323.00M
Selling, General & Admin	$1.03B	$1.04B	$1.11B	$1.12B	$1.12B
Operating Expenses	$1.33B	$1.34B	$1.43B	$1.46B	$1.44B
Operating Income	$652.00M	$653.00M	$827.00M	$515.00M	$738.00M
EBITDA	$874.00M	$902.00M	$1.07B	$755.00M	$967.00M
Pretax Income	$613.00M	$643.00M	$821.00M	$505.00M	$693.00M
Income Tax	$113.00M	$179.00M	$219.00M	$94.00M	$119.00M
Net Income	$486.00M	$446.00M	$589.00M	$389.00M	$560.00M
Diluted EPS	1.06	0.98	1.29	0.85	1.24
Diluted Shares	458.00M	457.00M	457.00M	457.00M	454.00M

GEHC Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$3.74B	$4.00B	$4.49B	$2.26B	$2.08B
Receivables	$4.47B	$4.68B	$4.85B	$4.74B	$4.91B
Inventory	$2.28B	$2.30B	$2.23B	$2.35B	$2.48B
Current Assets	$11.31B	$11.89B	$12.50B	$10.43B	$10.50B
Total Assets	$35.50B	$36.13B	$36.91B	$37.13B	$37.25B
Current Liabilities	$9.75B	$10.07B	$9.11B	$8.53B	$8.30B
Long-Term Debt	$8.27B	$8.28B	$9.49B	$10.13B	$10.09B
Total Debt	$10.72B	$10.74B	$10.46B	$10.58B	$10.54B
Total Liabilities	$25.55B	$25.91B	$26.31B	$26.23B	$26.03B
Retained Earnings	$4.29B	$4.71B	$5.28B	$5.65B	$6.20B
Shareholders' Equity	$9.71B	$9.99B	$10.38B	$10.67B	$10.97B
Working Capital	$1.56B	$1.82B	$3.40B	$1.90B	$2.19B
Net Debt	$6.54B	$6.28B	$5.51B	$7.87B	$8.01B

GEHC Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$94.00M	$593.00M	$1.05B	$290.00M	$168.00M
Capital Expenditure	-$86.00M	-$110.00M	-$134.00M	-$178.00M	-$100.00M
Free Cash Flow	$8.00M	$483.00M	$916.00M	$112.00M	$68.00M
Depreciation & Amortisation	$148.00M	$148.00M	$146.00M	$153.00M	$160.00M
Stock-Based Compensation	$34.00M	$38.00M	$36.00M	$35.00M	$45.00M
Investing Cash Flow	-$223.00M	-$148.00M	-$269.00M	-$2.50B	-$115.00M
Financing Cash Flow	$1.36B	-$165.00M	-$293.00M	$21.00M	-$236.00M
Dividends Paid	-$16.00M	-$16.00M	-$16.00M	-$16.00M	-$16.00M
Share Repurchases	-$100.00M	-$100.00M	$0.00	-$100.00M	-$200.00M
Net Change in Cash	$1.23B	$280.00M	$487.00M	-$2.19B	-$182.00M

Market Snapshot

About

GE HealthCare Technologies Inc. is a leading global medical technology and digital solutions company that spun off from General Electric in January 2023. The company develops and manufactures medical imaging equipment, diagnostics, monitoring systems, drug discovery tools, and biopharmaceutical manufacturing technologies. GE HealthCare's product portfolio includes CT scanners, MRI systems, ultrasound devices, and pharmaceutical diagnostics across four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. With operations in over 100 countries, the company serves healthcare providers, researchers, and pharmaceutical manufacturers worldwide.